RIPK3 and intestinal polyp: After IL-6R antibody treatment for 10 weeks, the anti-IL6-R-treated Apcmin/+Ripk3-/- mice showed fewer intestinal polyps than UT Apcmin/+Ripk3-/- mice (Figure 4C).